A relatively new term has been seen more and more in medical literature over the past few years: Axial spondyloarthritis (AxSpA).
Millions of Americans may suffer from a chronic disease and not even know it. The purpose of Spondylitis Awareness Month is to educate the public and shine a light on this under-recognized condition.
The FDA Arthritis Advisory Committee has recommended the approval of CT-P13 (Remsima), a biosimilar version of the TNF inhibitor infliximab (Remicade), for ankylosing spondylitis, rheumatoid arthritis, psoriasis, Crohn’s disease, and ulcerative colitis.
Dr. Paul I. Terasaki, Professor Emeritus of Surgery at the UCLA Geffen School of Medicine, passed away on January 25th, 2016 at the age of 86. Besides being one of the most important transplantation scientists, and establishing the largest transplantation registry of his time, Dr. Terasaki was responsible for discovering the linkage between HLA-B27 and ankylosing spondylitis in the U.S. in 1971.
Visit our careers page for available positions
16360 Roscoe Blvd. Ste. 100Van Nuys, CA 91406
(800) 777-8189 U.S. only
or (818) 892-1616*Please note: This is not a Crisis Hotline. If you are in a life-threatening crisis, please dial 911 for immediate help in the US. Please follow this link for crisis intervention resources.